Hospitalist Doctors in Alexandria, LA Accepting Medicare

4 Hospitalist doctors found. Showing 1 - 4

Muhannad Alqudsi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 4th St Ste 5a, Alexandria, LA 71301 Phone: 318-483-1961    Fax: 318-483-1964

Ronak Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 4th St Ste 3h, Alexandria, LA 71301 Phone: 318-441-1030

Randy Joseph Lamartiniere, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 26 Cooper Rd Unit B, Alexandria, LA 71303 Phone: 318-623-0170    Fax: 225-410-1181

Brian Carl Jobe, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Evanridge St, Alexandria, LA 71302 Phone: 318-442-8958

News Archive

Lexicon Pharmaceuticals proposes $95 million underwritten public offering of common stock

Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.

Intense experience in Haiti raises many difficult ethical questions, says Johns Hopkins emergency physician

In an essay published in this week's issue of the Journal of the American Medical Association, a Johns Hopkins emergency physician outlines how he and other physicians who worked in Haiti after the earthquake had to make emotionally difficult ethical decisions daily in the face of a crushing wave of patients and inadequate medical resources.

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Further advancing one of the largest Phase III trials for head and neck cancer in the world, CEL-SCI Corporation announced today that it has received approval from the Agency for Medicaments and Medical Devices of the government of Bosnia and Herzegovina to begin enrollment of subjects into the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection).

Hydroxychloroquine is not indicated for COVID-19 under any circumstances

The drug Hydroxychloroquine has long been studied as a treatment for malaria and autoimmune diseases. When the coronavirus pandemic spread across the globe, many countries resorted to using the drug in the hopes that it would improve outcomes of hospitalized patients affected by the coronavirus disease (COVID-19).

Read more Medical News

› Verified 4 days ago